drugset / Trial / NCT01275664
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
NaSingle-groupOpen-labelSupportive care
Summary
This clinical trial is studying how well granisetron, aprepitant, and dexamethasone work in preventing nausea and vomiting in patients receiving chemotherapy for stage II, stage III, or stage IV ovarian cancer. Granisetron patch, aprepitant and dexamethasone may help lessen or prevent nausea and vomiting in patients receiving chemotherapy for stage II, stage III, or stage IV ovarian cancer.
Timeline
- Start
- 2011-06
- Primary completion
- 2014-05
- Completion
- —
Outcome
Outcome not reported
Stopped: “Study terminated due to no patient population available”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | — | Intravenous |
| Subject | Dexamethasone | Small molecule | — | Oral |
| Subject | Granisetron | Other / unclassified | — | Other |
| Background | Carboplatin | Small molecule | — | Other |
| Background | Cisplatin | Other / unclassified | — | Other |